You have breast cancer. We’re here to help.
A breast cancer diagnosis is life-changing. At Cancer Treatment Centers of America® (CTCA), we’re here to help you and your loved ones make a more informed treatment decision. We encourage you to explore this area to learn more about the disease, what lies ahead and your treatment options.
Hear inspiring patient stories. Learn how our doctors create a personalized treatment plan for your diagnosis and needs. And if you have any questions along the way, please don’t hesitate to contact our team of cancer experts. We’re here to help you make sense of it all.
Breast cancer symptoms
Perhaps the most recognized symptom of breast cancer is a lump or mass in the breast tissue. While many women go to their doctor after finding a lump, they should also be aware of any other changes to the breast or nipple.
With the different types of breast cancer come a variety of related symptoms. For example, invasive ductal carcinoma (IDC), which forms in the milk ducts, may cause a distinct breast lump that you can feel. Invasive lobular carcinoma (ILC), which forms situs judi slot terbaik dan terpercaya no 1 in the milk-producing glands, may cause a thickening in the breast.
Breast cancer risk factors
Each year, more than 190,000 people are diagnosed with breast cancer. According to the National Cancer Institute, the incidence of breast cancer in the United States has decreased by about two percent from 1999 to 2006. The reason for the decrease is not completely understood.
Knowing the risk factors for breast cancer may help you take preventative measures to reduce the likelihood of developing the disease.
Breast cancer stages
Making an educated treatment decision begins with the stage, or progression, of the disease. Using the results from your diagnostic tests, your care team at Cancer Treatment Centers of America (CTCA) will develop an appropriate treatment plan for you.
If you have been recently diagnosed, we will review your pathology to confirm you have received the correct diagnosis and staging information, and develop a personalized treatment plan. If you have a recurrence, we will perform comprehensive testing and identify a treatment approach that is suited to your needs.
Breast cancer diagnostics and treatment
At each of our hospitals, you’ll find innovative breast cancer treatments and technologies—all under one roof. Our breast cancer experts use state-of-the-art diagnostic tools, including advanced imaging and laboratory tests, to evaluate breast cancer. This diagnostic evaluation takes about three to five days.
Then together, we develop a comprehensive breast cancer treatment plan that works for you. Your individualized plan will include advanced medical treatments and technologies, combined with integrative oncology services to help reduce https://www.crete3.org/ side effects and keep you strong in body, mind and spirit.
Breast cancer diagnostics and treatment
At each of our hospitals, you’ll find innovative breast cancer treatments and technologies—all under one roof. Our breast cancer experts use state-of-the-art diagnostic tools, including advanced imaging and laboratory tests, to evaluate breast cancer. This diagnostic evaluation takes about three to five days.
Then together, we develop a comprehensive breast cancer treatment plan that works for you. Your individualized plan will include advanced medical treatments and technologies, combined with integrative oncology services to help reduce side effects and keep you strong in body, mind and spirit.
Breast cancer diagnostics and treatment
At each of our hospitals, you’ll find innovative breast cancer treatments and technologies—all under one roof. Our breast cancer experts use state-of-the-art diagnostic tools, including advanced imaging and laboratory tests, to evaluate breast cancer. This diagnostic evaluation takes about three to five days.
Then together, we develop a comprehensive breast cancer treatment plan that works for you. Your individualized plan will include advanced medical treatments and technologies, combined with integrative oncology services to help reduce side effects and keep you strong in body, mind and spirit.
Breast cancer diagnostics and treatment
At each of our hospitals, you’ll find innovative breast cancer treatments and technologies—all under one roof. Our breast cancer experts use state-of-the-art diagnostic tools, including advanced imaging and laboratory tests, to evaluate breast cancer. This diagnostic evaluation takes about three to five days.
Then together, we develop a comprehensive breast cancer treatment plan that works for you. Your individualized plan will include advanced medical treatments and technologies, combined with integrative oncology services to help reduce side effects and keep you strong in body, mind and spirit.
Breast cancer treatment statistics and results
When you are told you have cancer and begin looking for treatment options, you may be concerned about life expectancy and quality of life. At Cancer Treatment Centers of America® (CTCA), we believe you have the right to know our statistics for breast cancer treatment outcomes, so you can choose the best cancer care for you and your family.
Breast cancer statistics
Each person’s cancer diagnosis is as distinct as the person it affects. Part of our promise to you and your family is to offer clear information, and powerful and thorough treatment options, all based on your individual needs.
Many cancer patients consider length of life and quality of life to be two of the most important statistics for breast cancer care, and they value a treatment experience that is as convenient and stress-free as possible. We are committed to educating patients and their families and we provide our breast cancer results in these areas to help you make more informed decisions for a longer, healthier life.
Breast cancer survival statistics & results
Survival Results: Breast CancerStatistical Methodology: Breast Cancer
Survival Results: Breast Cancer
Click here to review statistical methodology and limitations
At Cancer Treatment Centers of America® (CTCA), we understand that you may want to see information regarding the survival results of patients with metastatic breast cancer who were diagnosed and/or at least partly treated at our hospitals to help you and your family decide situs judi slot online yang gampang menang where to go for treatment, as part of many other factors you may be considering. Therefore, we asked an independent biostatistician to analyze the survival results of CTCA® patients.
The chart below shows the cancer survival rates for a group of 232 metastatic breast cancer patients who were diagnosed between 2000 and 2009. Each patient in the group was first diagnosed at CTCA and/or received at least part of their initial course of treatment at CTCA.
Breast survival ctca syr vertical
Of the CTCA metastatic breast cancer patients shown in the above chart, the estimated survival rate at six months was 95%. This means that six months after their diagnosis, 95% of the patients in this group were still living.
CTCA and SEER Survival Analysis
At Cancer Treatment Centers of America, we understand that you may also wish to see the survival rates of the group of metastatic breast cancer patients reported in the Surveillance, Epidemiology and End Results (SEER) database of the National Cancer Institute. SEER is a source of population-based information about cancer incidence and survival in the United States that includes the stage of cancer at the time of diagnosis and patient survival data. SEER collects information on cancer incidence, prevalence and survival from specific geographic areas that represent 28% of the population of the United States. It then makes this data available through its database at seer.cancer.gov.
Therefore, we asked an independent biostatistician to analyze both the survival rates of the group of CTCA patients and the group of patients included in the SEER database.
The objective of this analysis was to see how long each group of patients survived after their diagnosis. The results are shown in the chart below.
breast survival ctca seer 5yr vertical
In the case of metastatic breast cancer, 79% of CTCA patients who were diagnosed between 2000 and 2009 and/or at least partly treated at our hospitals survived 1.5 years after the initial diagnosis, while 57% of the SEER metastatic breast cancer patients survived for at least that long.
How the Samples Were Chosen for the Analysis
The CTCA sample included all eligible cancer patients from four of our five cancer registries, including CTCA at Southwestern Regional Medical Center in Tulsa, Oklahoma; CTCA at Midwestern Regional Medical Center in Zion, Illinois; CTCA at Eastern Regional Medical Center in Philadelphia, Pennsylvania; and CTCA at Western Regional Medical Center in Goodyear, Arizona. Our fifth hospital, located near Atlanta, Georgia, was not included because it was not open to patients until August 2012.
“Eligible” patients were those who were first diagnosed at a CTCA cancer center between 2000 and 2009 (including 2000 and 2009) and/or received at least part of their initial course of treatment at a CTCA cancer center. Across all the 11 cancer types whose survival results are presented on the CTCA website, 0.48% of the CTCA patients included in the analyses were diagnosed by CTCA, but received no initial course of treatment from CTCA. A similar statistic for each individual type of cancer included in the analysis is not currently available.
The independent biostatistician computed the survival outcomes of metastatic breast cancer patients from the CTCA database and metastatic breast cancer patients from the SEER database who were diagnosed between 2000 and 2009. In both cases, the patients had been diagnosed with metastatic (distant) cancer – cancer that had traveled from the primary site (breast) to one or more distant sites in the body where it continued to grow.
The CTCA sample is relatively small because only metastatic breast cancer patients who had been initially diagnosed at CTCA and/or received at least part of their initial course of treatment at CTCA were included. These factors significantly reduced the size of the CTCA sample, which means that the estimates reflected in the survival chart may be subject to high variation and may not be replicated in the future when we have a larger CTCA sample for analysis.
For a full, technical explanation of the methodology used in the analysis and a detailed description of the CTCA and SEER patient groups included , click on the Statistical Methodology: Breast Cancer tab above, and for more information about the SEER program, go to seer.cancer.gov
We also want to be sure you understand that cancer is a complex disease and each person’s medical condition is different; therefore, CTCA makes no claims about the efficacy of specific treatments, the delivery of care, nor the meaning of the CTCA and SEER analysis. Not all cancer patients who are treated at a CTCA hospital may experience these same results.
* The SEER data represent national results over a large number of institutions and have been included for illustrative purposes. They are not intended to represent a controlled study and/or a perfect analysis of the CTCA and SEER data because of variability in the sample sizes of the two data bases, the clinical condition(s) of the patients treated, and other factors.
Material from http://www.cancercenter.com/